Clinical decisions in patients with diabetes and other cardiovascular risk factors. A statement of the Spanish Society of Internal Medicine
- PMID: 24602600
- DOI: 10.1016/j.rce.2013.12.014
Clinical decisions in patients with diabetes and other cardiovascular risk factors. A statement of the Spanish Society of Internal Medicine
Abstract
Although the mortality associated to cardiovascular diseases (CVD) has been reduced in the last decades, CVD remains the main cause of mortality in Spain and they are associated with an important morbidity and a huge economic burden. The increasing prevalence of obesity and diabetes could be slowing down the mortality reduction in Spain. Clinicians have often difficulty making clinical decisions due to the multiple clinical guidelines available. Moreover, in the current context of economic crisis it is critical to promote an efficient use of diagnostic and therapeutic proceedings to ensure the viability of public health care systems. The Spanish Society of Internal Medicine (SEMI) has coordinated a consensus document to answer questions of daily practice with the aim of facilitating physicians' decision-making in the management of diabetes and cardiovascular risk factors from a cost-efficiency point of view.
Keywords: Agregación plaquetaria; Cardiovascular diseases; Diabetes mellitus; Dislipidemia; Dyslipidemia; Enfermedades cardiovasculares; Hipertensión; Hypertension; Obesidad; Obesity; Platelet aggregation; Prevención primaria; Prevención secundaria; Primary prevention; Secondary prevention.
Copyright © 2013 Elsevier España, S.L. All rights reserved.
Comment in
-
Clinical decision making and cardiovascular risk factors: what about the Heart Team?Rev Clin Esp (Barc). 2014 May;214(4):200-1. doi: 10.1016/j.rce.2014.02.006. Epub 2014 Mar 21. Rev Clin Esp (Barc). 2014. PMID: 24661613 No abstract available.
Similar articles
-
[Cholesterolemia control in Spain, 2000. A tool for cardiovascular disease prevention. Ministry of Health and Consumption, Spanish Society of Cardiology and Spanish Society of Arteriosclerosis].Rev Esp Salud Publica. 2000 May-Jun;74(3):215-53. Rev Esp Salud Publica. 2000. PMID: 10918811 Spanish.
-
[Spanish adaptation of the 2016 European Guidelines on cardiovascular disease prevention in clinical practice].Hipertens Riesgo Vasc. 2017 Jan-Mar;34(1):24-40. doi: 10.1016/j.hipert.2016.11.006. Epub 2016 Dec 23. Hipertens Riesgo Vasc. 2017. PMID: 28017552 Spanish.
-
Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients.Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):589-93. doi: 10.1097/HJR.0b013e328308ba61. Eur J Cardiovasc Prev Rehabil. 2008. PMID: 18830087 Clinical Trial.
-
[European Guidelines on Cardiovascular Disease Prevention in Clinical Practice. Spanish adaptation of the CEIPC 2008].Neurologia. 2009 Sep;24(7):465-84. Neurologia. 2009. PMID: 19921557 Review. Spanish.
-
Psoriasis: a skin disease associated with increased cardiovascular risk.Actas Dermosifiliogr. 2012 Sep;103(7):595-8. doi: 10.1016/j.ad.2012.01.006. Epub 2012 Mar 31. Actas Dermosifiliogr. 2012. PMID: 22465257 Review. English, Spanish.
Cited by
-
Treatment persistence and adherence and their consequences on patient outcomes of generic versus brand-name statins routinely used to treat high cholesterol levels in Spain: a retrospective cost-consequences analysis.Lipids Health Dis. 2018 Dec 6;17(1):277. doi: 10.1186/s12944-018-0918-y. Lipids Health Dis. 2018. PMID: 30522491 Free PMC article.
-
Unanswered clinical questions in the management of cardiometabolic risk in the elderly: a statement of the Spanish Society of Internal Medicine.BMC Cardiovasc Disord. 2014 Dec 18;14:193. doi: 10.1186/1471-2261-14-193. BMC Cardiovasc Disord. 2014. PMID: 25519433 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical